Schedule 13G ownership disclosure

ACHILLES THERAPEUTICS PLC

Security class unavailable · CUSIP: 00449L102

Event date: 2024-03-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-082106
Form type
SC 13G/A
Filer
Achilles Therapeutics plc
CIK
CIK 1830749
Filed
Mar 29, 2024
Reporting period
Mar 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub